40520-14-7

Basic information

• Product Name: 4-(Dodecylthio)butyric acid
• Synonyms: 4-(Dodecylthio)butyric acid
• CAS NO: 40520-14-7
• Molecular Formula: C16H32O2S
• Molecular Weight: 288.48908
• Mol File: 40520-14-7.mol

Chemical Properties

• Boiling Point: 419°C at 760 mmHg
• Flash Point: 207.2°C
• Appearance: /
• Density: 0.957g/cm³
• Vapor Pressure: 3.39E-08mmHg at 25°C
• Refractive Index: 1.481
• CAS DataBase Reference: 4-(Dodecylthio)butyric acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(Dodecylthio)butyric acid(40520-14-7)
• EPA Substance Registry System: 4-(Dodecylthio)butyric acid(40520-14-7)

Safety Data

• Hazardous Substances Data: 40520-14-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C16H32O2S/c1-2-3-4-5-6-7-8-9-10-11-14-19-15-12-13-16(17)18/h2-15H2,1H3,(H,17,18)

Upstream product

• 197514-15-1 (3-chloro-propyl)-dodecyl sulfide 
• 112-55-0 1-dodecylthiol 
• 625-38-7 but-3-enoic acid 
• 26960-77-0 sodium dodecanethiolate 
• 2969-81-5 Ethyl 4-bromobutyrate 

Relevant articles and documents

Therapeutic use of acyl glycerols and the nitrogen- and sulphur- containing analogues thereof

The invention relates to the use of acyl glycerols and the nitrogen- and sulfur-containing analogues thereof in the therapeutic field, particularly in human health. The inventive compounds have advantageous pharmacological properties and are particularly of use for the prevention or treatment of neurodegenerative diseases.

Therapeutic use of of acyglycerols and the nitrogen-and sulphur-containing analogues thereof

The invention relates to the use of acylglycerols and the nitrogen- and sulfur-containing analogues thereof in therapy, particularly for the treatment of cerebral ischemia. The invention further relates to methods for preparing said derivatives, novel compounds, in particular acylglycerols, the nitrogen- and sulfur-containing analogues thereof and methods for preparing same.

Fatty acid compounds, preparation and uses thereof

The invention concerns novel molecules, their preparation and their uses, in particular in the field of human and veterinary medicine and cosmetics. The inventive compounds are partly fatty acid derivatives and exhibit advantageous pharmacological and cosmetic properties. The invention also concerns various uses of said compounds, the pharmaceutical compositions containing them and methods for preparing them. The inventive compounds are useful in particular for preventing and/or treating dyslipidemiae, cardiovascular diseases, syndrome X, restenosis, diabetes, obesity, hypertension, certain cancers, dermatological diseases and in cosmetics, for fighting against skin aging and its effects notably against wrinkles and the like